Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ARSJ |
| Upstream (Parents) |
|---|
| (<<) ATP2C1 → ARSJ |
| (<<) BPGM → ARSJ |
| (<<) CDKN2A → ARSJ |
| (<<) ELF1 → ARSJ |
| (<<) ENO1 → ARSJ |
| (<<) FOXA2 → ARSJ |
| (<<) GNB1 → ARSJ |
| (<<) LRP3 → ARSJ |
| (<<) NRIP3 → ARSJ |
| (<<) PDIA3 → ARSJ |
| (<<) PDK1 → ARSJ |
| (<<) PITPNC1 → ARSJ |
| (<<) RHOC → ARSJ |
| (<<) SLC20A1 → ARSJ |
| (<<) STEAP1 → ARSJ |
| (<<) STK17B → ARSJ |
| (<<) TCEB1 → ARSJ |
| (<<) TTC9 → ARSJ |
| (<<) VAV3 → ARSJ |
| (<<) YRDC → ARSJ |
| (<<) YWHAB → ARSJ |
| Downstream (Children) |
|---|
| ARSJ → CAMKK2 (>>) |
| ARSJ → DHRS9 (>>) |
| ARSJ → DUSP6 (>>) |
| ARSJ → EGF (>>) |
| ARSJ → FER1L4 (>>) |
| ARSJ → HDAC9 (>>) |
| ARSJ → MAP3K5 (>>) |
| ARSJ → MEX3D (>>) |
| ARSJ → ROR1 (>>) |
| ARSJ → SLC29A1 (>>) |
| ARSJ → SMAD5 (>>) |
| ARSJ → SOX2 (>>) |
| ARSJ → STK11 (>>) |
